Global-E Online Ltd. (GLBE) Spending and interest coverage
- R&D / revenue · 12 months: Value 12.76%; Formula and calculation Research and development expense / revenue. Period ending 2025-12-31..
- Stock-based compensation / revenue · 12 months: Value 4.09%; Formula and calculation Share-based compensation / revenue. Period ending 2025-12-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 12.76% | Research and development expense / revenue. Period ending 2025-12-31. $122.75M ÷ $962.20M × 100 ≈ 12.76% |
| Stock-based compensation / revenue · 12 months | 4.09% | Share-based compensation / revenue. Period ending 2025-12-31. $39.34M ÷ $962.20M × 100 ≈ 4.09% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 122.75M USD | Research and Development Expense |
| Revenue | 962.20M USD | |
| Stock-based compensation | 39.34M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 71.67M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $122.75M | $962.20M | $39.34M | $71.67M | (m) | 12.76% | 4.09% | (m) | (m) |
| 2024-12-31 | $105.49M | $752.76M | $39.16M | $-67.93M | (m) | 14.01% | 5.20% | (m) | (m) |
| 2023-12-31 | $97.57M | $569.95M | $44.96M | $-137.06M | (m) | 17.12% | 7.89% | (m) | (m) |
| 2022-12-31 | $81.21M | $409.05M | $38.91M | $-189.32M | (m) | 19.85% | 9.51% | (m) | (m) |
| 2021-12-31 | $29.76M | $245.27M | $12.00M | $-65.66M | (m) | 12.13% | 4.89% | (m) | (m) |
| 2020-12-31 | $15.40M | $136.38M | $3.96M | $8.41M | (m) | 11.29% | 2.90% | (m) | (m) |
| 2019-12-31 | $12.03M | $65.85M | $221.00K | $-4.95M | (m) | 18.27% | 0.34% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.